Purchases and Sales Made in Q3 2022 in Harvard Bioscience Inc (HBIO)
This table provides information about the institutional ownership of Harvard Bioscience Inc (HBIO) during Q3 2022. The information is specifically focused on institutions that hold shares of HARVARD BIOSCIENCE INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-27K- 34.94% |
$62.9K - $106K
|
50.2K
$108K
|
|
|
Nov 14, 2022
Q3 2022
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-30K- 74.44% |
$69.9K - $118K
|
10.3K
$22K
|
|
|
Nov 08, 2022
Q3 2022
|
Riverwater Partners LLC
|
SELL
|
- |
-35.9K- 38.5% |
$83.6K - $141K
|
57.3K
$123K
|
|
|
Nov 14, 2022
Q3 2022
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-39.4K- 2.57% |
$91.9K - $155K
|
1.49M
$3.2M
|
|
|
Nov 14, 2022
Q3 2022
|
Parkman Healthcare Partners LLC
Stamford, CT |
SELL
|
- |
-46.4K- 13.19% |
$108K - $182K
|
305K
$653K
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-48.7KClosed |
$113K - $191K
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-114K- 83.27% |
$266K - $448K
|
23K
$49.1K
|
|
|
Nov 03, 2022
Q3 2022
|
Royce & Associates LP
|
SELL
|
- |
-122K- 7.53% |
$284K - $478K
|
1.5M
$3.21M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-134K- 89.77% |
$312K - $524K
|
15.2K
$32.6K
|
|
|
Nov 10, 2022
Q3 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-135K- 7.21% |
$316K - $531K
|
1.74M
$3.73M
|
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-150K- 14.96% |
$349K - $587K
|
851K
$1.82M
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-185K- 47.38% |
$432K - $726K
|
206K
$440K
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-423K- 68.81% |
$985K - $1.66M
|
192K
$410K
|
|
|
Nov 14, 2022
Q3 2022
|
Portolan Capital Management, LLC
Boston, MA |
SELL
|
- |
-1.11M- 45.26% |
$2.59M - $4.35M
|
1.34M
$2.87M
|